Pharma-Bio Serv (PBSV) Stock Price

Pharma-Bio Serv Inc is primarily active in the life sciences and biotechnology industries.

The main competitors of Pharma-Bio Serv Inc in the market include companies like Charles River Laboratories International Inc, Eurofins Scientific SE, and Laboratory Corporation of America Holdings. These companies also operate in the life sciences industry, providing various services and solutions related to pharmaceuticals, biomedical research, and clinical diagnostics.

Pharma-Bio Serv Inc is a reputable company that operates in the life sciences industry. Founded in 1993, the company has a strong history of providing comprehensive compliance, validation, and laboratory services to various sectors including pharmaceuticals, biotechnology, and healthcare. With its headquarters in Puerto Rico, Pharma-Bio Serv Inc has successfully expanded its operations globally, catering to a diverse range of clients. The company's commitment to quality and regulatory compliance has established its reputation as a trusted partner in the industry. Pharma-Bio Serv Inc continues to thrive as a leading provider of essential services, supporting the advancement of critical healthcare solutions worldwide.

Pharma-Bio Serv Inc has achieved several significant milestones in its history. The company has successfully expanded its presence in the life sciences industry by delivering high-quality compliance and validation support services to clients globally. Pharma-Bio Serv Inc has also strengthened its position by acquiring key businesses and forming strategic partnerships. Additionally, the company has demonstrated consistent growth and profitability, further solidifying its reputation as a leader in the field. Pharma-Bio Serv Inc continues to strive for excellence, driving innovation and offering exceptional solutions to meet the evolving needs of its clients in the pharmaceutical and biotech sectors.

Pharma-Bio Serv Inc, a leading company in the pharmaceutical and biotechnology industry, has a strong presence in various countries and regions worldwide. The primary focus of Pharma-Bio Serv Inc includes Latin America, the Caribbean, and the United States. With a dedicated team and a robust network of clients, Pharma-Bio Serv Inc delivers its exceptional services and solutions across these regions. By leveraging its expertise and strategic partnerships, Pharma-Bio Serv Inc continues to expand its footprint in these markets, catering to the needs of the growing pharmaceutical and biotechnology sectors.

Pharma-Bio Serv Inc represents a set of core values and a strong corporate philosophy. This company is committed to providing exceptional quality and regulatory compliance services to the life sciences industry. Pharma-Bio Serv Inc's values comprise integrity, professionalism, innovation, and client satisfaction. With a customer-centric approach, they prioritize building long-term relationships and delivering tailored solutions. Pharma-Bio Serv Inc strives to maintain the highest ethical standards and ensure the success of their clients by offering reliable and efficient services. Through their expertise and dedication, they contribute to the growth and advancement of the pharmaceutical and biotech sectors.

Converted at the current exchange rate, the Pharma-Bio Serv share trades at 0.47 EUR (0.52 USD).

Pharma-Bio Serv Inc is a company that focuses on providing life science solutions and services to help clients achieve their scientific and regulatory goals. The company offers high-quality products and services in the areas of bioanalytics, compliance and validation, quality control, and regulatory support.

The expected revenue of Pharma-Bio Serv is 11.00 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Pharma-Bio Serv is 917,888.00 USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Pharma-Bio Serv is currently 12.98. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Pharma-Bio Serv stock.

The price-to-sales ratio (P/S) of Pharma-Bio Serv is currently 1.08. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Pharma-Bio Serv stock.

The Eulerpool Quality Score for Pharma-Bio Serv is 2/10.

The ISIN of Pharma-Bio Serv is US71711N1000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Pharma-Bio Serv is PBSV. The ticker symbol is used to trade Pharma-Bio Serv shares on the stock exchange.